Compounds are provided for use with kinases that comprise a compound selected from the group consisting of:
wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
[EN] KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASES
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2009129401A1
公开(公告)日:2009-10-22
Compounds are provided for use with kinases that comprise a compound selected from the group consisting of formula (I): wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Regiochemical Flexibility: The Optional Functionalization of 2,3,5-Trihalopyridines at the 4- or 6-Position
ice to afford the carboxylic acids. Upon neutralization, the 6-iodopyridines were obtained. These compds. readily exchanged the heavy halogen for metal when treated with isopropylmagnesiumchloride. In this way, functional groups could be selectively introduced in the 6-position. Employing carbon dioxide routinely as the model electrophile, trihalopyridinecarboxylic acids were formed which, all unknown
synthesized in 2 steps from the corresponding trichloropyridine. This novel pentahalogenated pyridine gives access to fully arylated pyridines with up to four different aryl rings by iterative Suzuki–Miyaura reactions.